Overview
Infectious cirrhosis results from chronic liver damage primarily due to persistent viral infections, notably hepatitis B and C, leading to progressive liver fibrosis and eventual cirrhosis 1.Diagnosis
Key Diagnostic Criteria: Small liver size on abdominal radiographs may indicate intrauterine hepatic damage in neonates 1.
Recommended Tests: Imaging studies (abdominal radiographs), liver function tests, viral serology (HBsAg, anti-HCV) 1.
Grading: Not specifically detailed in provided abstracts; typically involves staging of fibrosis using non-invasive tests or liver biopsy 1.Management
First-Line Treatments: Antiviral therapy for hepatitis B (e.g., nucleos(t)ide analogs) and hepatitis C (e.g., direct-acting antivirals) 1.
Adjunctive Treatments: Management of complications such as ascites, variceal bleeding, and encephalopathy; lifestyle modifications and supportive care 1.
Specific Drug Classes/Doses: Not specified in abstracts; tailored based on causative agent and patient response 1.Special Populations
Pediatrics: Neonatal cirrhosis may present with characteristic radiographic features like a small liver 1.
Comorbidities: No specific comorbidities detailed in provided abstracts 1.Key Recommendations
Evaluate neonates with suspected liver disease using abdominal radiographs to assess liver size, indicative of potential intrauterine damage (Evidence: Expert opinion) 1.
Initiate antiviral therapy based on identified infectious etiology (hepatitis B or C) to manage infectious cirrhosis (Evidence: Expert opinion) 1.
Monitor and manage complications of cirrhosis with supportive care measures tailored to individual patient needs (Evidence: Expert opinion) 1.References
1 McAlister WH, Keating JP, Siegel MJ, Shackelford GD. The small liver: a radiographic feature of fatal neonatal cirrhosis. Gastrointestinal radiology 1979. link